Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Completed × Lead × Clear all

Phase

Phase NA 2 Phase 4 1 Phase 3 1 Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Pancreatic Ductal 1 Adenocarcinoma 1

Interventions

Cyclophosphamide 115 Paclitaxel 109 Gemcitabine 109 Radiotherapy 99 Carboplatin 96 pembrolizumab 93 Cisplatin 89 Nivolumab 82 Docetaxel 79 Rituximab 71 Lenalidomide 66 Bevacizumab 59 Cytarabine 58 Dexamethasone 57 Etoposide 55 Peripheral Blood Stem Cell Transplantation 54 Capecitabine 54 Filgrastim 53 fludarabine phosphate 52 Fluorouracil 52 Temozolomide 51 Oxaliplatin 50 Everolimus 50 Irinotecan 48 Prednisone 46 Doxorubicin 45 Cetuximab 45 Erlotinib Hydrochloride 44 Melphalan 43 Bortezomib 42

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01808638 2016-03-11

Atu027-I-02

Silence Therapeutics GmbH

Phase 1/2 Completed

Gastrointestinal

Adenocarcinoma, Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡